BioCentury | Jan 21, 2008
Clinical News

TOP2A FISH pharmDx regulatory update

...Dako received FDA clearance to market its TOP2A FISH pharmDx genetic test to assess the risk of tumor...
...increased likelihood of tumor recurrence or decreased long-term survival. Dako A/S , Glostrup, Denmark Product: TOP2A FISH pharmDx...
BioCentury | Jan 15, 2008
Company News

FDA approves Dako's breast cancer test

...FDA approved the TOP2A FISH pharmDx genetic test from Dako (Glostrup, Denmark) to assess the risk of tumor...
Items per page:
1 - 2 of 2